Molecular Cytogenetics Lab, Dept. of Hematology,
University
Hospital of Salamanca,
Spain
[email protected]
Full professor in Hematology (Internal Medicine) at the Medical School of the University of Salamanca. Senior Physician of the Dept. of Hematology in the University Hospital of Salamanca. Principal Investigator of the “Cancer Genetics” group at IBSAL.
He is actively working in Cancer Genetics, mainly in haematological malignancies, in the last 25 years. The main research lines were the use of the molecular cytogenetics and the massive genetic techniques to improve the diagnosis and prognosis of the patients with leukemia, lymphoma or myeloma. Actually he is the coordinator of the project HARMONY, a Big Data for Better Outcomes Initiative (H2020), aimed to improve the patient outcomes in hematological malignancies by using Big Data.
Education
- 1983: "Bachelor in Medicina y Cirugía" (M.D.), University of Salamanca, Spain.
- 1990: Ph.D. obtained with the work "Blastic Transformation of chronic myeloproliferative and myelodysplastic syndromes ". Salamanca.
- 1990: Specialization in Hematology (University Hospital of Salamanca)
- 1993-4: Posdoc specialization in Cancer Genetics at the “Center for Human Genetics”, Leuven Belgium
Present Position
- 1990-present: Staff Doctor and Director of the Molecular Cytogenetics Lab, Dept. of Hematology, University Hospital of Salamanca. Licence no. 373704782
- 2005-17: Professor of Medicine, University of Salamanca.
- 2017- : Full Professor of Medicine, University of Salamanca
- 2008-Codirector, Cellular and Molecular Diagnostic Unit, Center for Cancer Research, University of Salamanca.
- 2011- : PI of the Group “Molecular Genetics in Oncohematology, IBSAL
- 2014- : Vice-director Dept Medicine, University of Salamanca
Participation in Conferences: Invited talks: 76; communications: over 500 PhD Promotor: 15; Patents: 2; IP Clinical trials: 28
Projects funded: 57, Coordinator of HARMONY project (BD4BO), 2017
Main research lines: cancer genetics, genomics, epigenetics, leukemia, lymphoma, microarrays, pharmacogenomics, NGS, DNA editing, Big Data